Induction of potent anti-tumor responses while eliminating systemic side effects via liposome-anchored combinatorial immunotherapy
Immunostimulatory therapies that activate immune response pathways are of great interest for overcoming the immunosuppression present in advanced tumors. Agonistic anti-CD40 antibodies and CpG oligonucleotides have previously demonstrated potent, synergistic anti-tumor effects, but their clinical us...
Main Authors: | Kwong, Brandon, Liu, Haipeng, Irvine, Darrell J |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Biological Engineering |
Format: | Article |
Language: | en_US |
Published: |
Elsevier
2015
|
Online Access: | http://hdl.handle.net/1721.1/99424 https://orcid.org/0000-0002-4267-237X |
Similar Items
-
Localized Immunotherapy via Liposome-Anchored Anti-CD137 + IL-2 Prevents Lethal Toxicity and Elicits Local and Systemic Antitumor Immunity
by: Kwong, Brandon, et al.
Published: (2014) -
Liposome-anchored local delivery of immunomodulatory agents for tumor therapy
by: Kwong, Brandon (Brandon Wai-Sing)
Published: (2013) -
Combinatorial Polydopamine-Liposome Nanoformulation as an Effective Anti-Breast Cancer Therapy
by: Lu W, et al.
Published: (2023-02-01) -
Polysaccharide-anchored fatty acid liposome
by: Tan, H.W., et al.
Published: (2013) -
Nanoparticle anchoring targets immune agonists to tumors enabling anti-cancer immunity without systemic toxicity
by: Zhang, Yuan, et al.
Published: (2018)